THE PRESENCE of lymphocytes sensitized to leukaemia-associated antigens has often been demonstrated in patients with acute leukaemia, using various techniques to assess cellular immunity such as lymphocyte blastogenesis, lymphocyte mediated cytotoxicity and delayed cutaneous hypersensitivity (Freedman and Kourilsky, 1969; Viza et al., 1969; and Leventhal, 1971; Santos et al., 1973; Anderson et al., 1974; Oren and Herberman, 1971 and Leventhal et al., 1972) . Attempts have been made to boost leukaemiaspecific immunity (Powles et al., 1971 and Gutterman et al., 1973b) , and to correlate the presence and degree of cellular immunity with the clinical stage of the disease (Gutterman et al., 1972a (Gutterman et al., , 1973c Char et al., 1973) .
Leukaemia-specific cellular immunity in chronic myeloid leukaemic patients (CML) has not, however, been reported All correspondence to S. G. Gangal. frequently. Oren and Herberman (1971) showed that 30%0 of CML patients specifically responded to low concentrations of solubilized autochthonous leukaemic cell membrane antigens in skin tests.
In the present report attempts have been made to study leukaemia-specific reactivity in CML patients in remission to solubilized autochthonous and allogeneic leukaemic cell membrane antigens by leucocyte migration inhibition tests. It was feasible to undertake these investigations because CML occurs frequently in India.
MATERIALS AND METHODS
Antigens.-Leukaemic cells were collected from the peripheral blood of 15 CML patients when they were first admitted to the Tata Memorial Hospital. They were diagnosed as CML on the basis of clinical evidence and bone marrow picture. They presented a high WBC count in the peripheral blood, ranging from 80,000 to 200,000. The bone marrow picture showed hypercellularity with granulocytes in all stages of differentiation and the ratio of M: E varying from 10: 1 to 20: 1.
Ten ml of blood was withdrawn in 4 ml of dextran-citrate mixture (6% Dextran, mol. wt. 110,000 with equal volume of 5% sodium citrate) from 15 CML patients. In three cases, one subsequent relapse sample each and in one case, two subsequent relapse samples were also collected. The RBCs were allowed to settle for 30 min at room temperature. The supernatant WBCs were washed three times and suspended in 10 ml saline. The cells were frozen and thawed rapidly six times in normal saline, with the help of dry ice. The lysis of cells was checked microscopically. The cellular extract was further subjected to membrane extraction procedure using sodium chloride solutions of graded molarity, as described by Oren and Herberman (1971) . Supernatants from all the extracts were pooled, clarified by centrifugation at 500 g for 10 min, and finally centrifuged at 105,000 g for 60 min. The pellet obtained was suspended in MEM and passed through millipore filter (0-45 jtm). The protein was finally adjusted to 50 ,ug/0-1 ml of MEM before using for the experiment.
Leucocyte samples for testing.-Remission leucocytes from 5 CML patients from whom leukaemic cell antigens were prepared (autochthonous combinations), as well as from 14 other CML patients (allogeneic combinations) were tested for inhibition of migration. Remission patients were either on maintenance therapy with busulfan (2 mg twice a week), or free from any drug treatment when tested. They were tested between 2 months to 2 years of remission period. None of them had received any blood transfusions. The peripheral WBC count raniged from 8000 to 15,000 at the time of testing. They were clinically and haematologically free of the disease.
Leucocyte migration inhibition (LMI)
-The procedure utilized in these studies was as described by Cochran et al. (1973b) , with slight modifications. Ten ml of peripheral blood from CML patients in remission and normal individuals was collected in dextran-citrate mixture. In some cases 6% Dextran was added to heparinized blood. RBCs were allowed to settle at room temp. for 30 min. The leucocyterich plasma was centrifuged. The leucocytes were washed 3 times with saline and finally suspended in MEM to contain approximately 10 x 106 leucocytes per 0-1 ml. The cell viability was checked with erythrocin B. Ten ,u of cell suspension was drawn in 20 ,ul micropets, so as to allow uniformity in cell number in every experiment. The capillaries were sealed and centrifuged at 1500 rev/min. They were cut at the cell-medium interface. Two capillaries were fixed in each migration chamber (perspex round chamber with outer diameter of 2 cm and inner diameter of 1-6 cm, depth 2 mm and capacity 0-5 ml) with silicon grease.
The chamber was then filled with 0-5 ml of medium containing MEM (Aindersoin et al., 1970; Mavligit et al., 1972; Braun et al., 1972; Cochran et al., 1973a Cochran et al., , 1974 and Kjaer, 1974 
